Company Andros Pharmaceuticals Co.,Ltd

Equities

6917

TW0006917008

Pharmaceuticals

End-of-day quote Taipei Exchange 03:30:00 20/05/2024 am IST 5-day change 1st Jan Change
21.2 TWD -2.08% Intraday chart for Andros Pharmaceuticals Co.,Ltd -1.40% -14.86%

Business Summary

Andros Pharmaceuticals Co Ltd is a Taiwan-based company mainly engaged in the research, design, development, manufacture and sales of novel drug delivery systems and liposome formulation-related products. The products are focused on topical drugs and are developed with a focus on pain-related indications. The Company is mainly engaged in the authorization of product technology transfer, as well as the manufacture and sales of niche generic drugs and high-end skin care products. Niche generic drugs and high-end skin care products include LALP Cream, which is used for anesthesia before minor skin surgery and laser treatment; iMinos Solution, which is used for the treatment of androgenetic alopecia; and deoxyribonucleic acid (DNA) repair enzyme liposome (LipoT4N5), which has anti-wrinkle, anti-sun and anti-aging effects. The products are mainly sold in Hong Kong and Taiwan.

Managers

Managers TitleAgeSince
Chief Executive Officer - 01/08/01
Chief Operating Officer - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 44,772,000 44,324,280 ( 99.00 %) 0 99.00 %

Company contact information

Andros Pharmaceuticals Co., Ltd.

6/F, No. 22 Sector 2, Shengyi Road

302 61, Zhubei

+

http://www.androspharma.com
address Andros Pharmaceuticals Co.,Ltd(6917)
  1. Stock Market
  2. Equities
  3. 6917 Stock
  4. Company Andros Pharmaceuticals Co.,Ltd
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW